INTERNATIONAL PATENT: DAAN BIOTHERAPEUTICS, INC., 주식회사 다안바이오테라퓨틱스 FILES APPLICATION FOR "NOVEL ANTI-CEACAM5 ANTIBODY AND THERAPEUTIC AGENT USE THEREOF"

GENEVA, Jan. 27 -- DAAN BIOTHERAPEUTICS, INC. (#3F, 366 Hangang-daero,Yongsan-gu,Seoul 04323), 주식회사 다안바이오테라퓨틱스 (서울특별시용산구한강대로 366, 3층) filed a patent application (PCT/KR2025/010115) for "NOVEL ANTI-CEACAM5 ANTIBODY AND THERAPEUTIC AGENT USE THEREOF" on Jul 10, 2025. With publication no. WO/2026/019161, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO). ...